Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Partners with Leading Organizations to Advance Education of Young Women and Girls in Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D)

[PR Newswire] – NEW BRUNSWICK, N.J., June 6, 2016 /PRNewswire/ — Johnson & Johnson (JNJ) is partnering with leading non-profit organizations FHI 360 and JA (Junior Achievement) Worldwide to advance the education of young women and girls in Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D). Through these partnerships, the company intends to reach one million girls between the ages of 5 and 18 by 2020. This is part of a broader effort Johnson & Johnson is making to accelerate the development of women leaders and to support women at all stages of their life to improve global health and well-being and drive sustainable economic growth. Read more on this. Johnson & Johnson (JNJ) , with a current value of $317.18B, ended session yesterday at $114.76. Looking at the equity, the company’s one day range is $114.93 to $115.37 with a trailing 52-week range being $81.79 to $115.39. JNJ shares are currently priced at 17.36x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -0.21x forward p/e ratio. The company pays shareholders $3.20 per share annually in dividends, yielding 2.79%. According to a consensus of 19 analysts, the earnings estimate of $1.69 per share would be $0.02 worse than the year-ago quarter and a $0.03 sequential increase. In looking at the bigger picture, the full-year EPS estimate of $6.61 would be a $0.41 better when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $17.98 Billion. If realized, that would be a 1.07% increase over the year-ago quarter. More recently, Standpoint Research Initiated JNJ at Sell (May 20, 2016). Previously, Goldman upgraded JNJ from Sell to Neutral. Investors should keep in mind is that the average price target is $117.44, which is 2.34% above where the stock opened this morning. See more in (NYSE:JNJ) Similar Articles: Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Joins First Industry-wide Call for New Collective Action to Address Antimicrobial Resistance Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to cut about 3000 jobs Company Update (NYSE:JNJ): Johnson & Johnson Partners with Leading Universities to Advance Women’s Education in Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D)